Juniper Pharma (JNP) Tops Q4 EPS by 7c, Miss on Revenues
Note: EPS may not be comparable
Juniper Pharma (NASDAQ: JNP) reported Q4 EPS of ($0.04), $0.07 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $11.4 million versus the consensus estimate of $16 million.
For earnings history and earnings-related data on Juniper Pharma (JNP) click here.